Christiana Fogg

Title: Christiana Fogg: Innovator in Poxvirus Vaccine Development

Introduction

Christiana Fogg is a notable inventor based in Germantown, MD (US), recognized for her contributions to the field of vaccine development. With a focus on poxvirus subunit vaccines, she has made significant strides in medical innovation. Her work has led to the filing of two patents that showcase her expertise and dedication to advancing healthcare solutions.

Latest Patents

Christiana Fogg's latest patents include compositions, methods, and kits relating to poxvirus subunit vaccines. The first patent is directed to a poxvirus vaccine comprising a soluble truncated poxvirus envelope protein. This invention also encompasses a vaccine that includes a nucleic acid encoding such proteins. Additionally, it features an antibody that specifically binds to the proteins and nucleic acid encoding them. The patent outlines methods for preventing and treating poxvirus infections using the aforementioned vaccine, antibody, protein, and nucleic acid encoding them.

Career Highlights

Throughout her career, Christiana Fogg has worked with prestigious institutions such as the University of Pennsylvania and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Gary H Cohen and John Charles Whitbeck. Their collaborative efforts have further enhanced the impact of her work in vaccine development.

Conclusion

Christiana Fogg's innovative contributions to poxvirus vaccine research exemplify her commitment to improving public health. Her patents and collaborations reflect her significant role in advancing medical science.